早期未分化关节炎治疗下的临床与影像学病程不依赖于诊断时侵蚀关节数量:瑞士前瞻性观察队列结果
在瑞士SCQM类风湿关节炎队列中,592例早期未分化关节炎患者(病程≤1年、未用过DMARDs)中240例不符合2010年ACR/EULAR分类标准,其中133例有影像学关节炎、50例无影像学关节炎。平均观察4年,两组DAS-28和HAQ评分无差异;初始无影像学关节炎组侵蚀评分进展更高(每年3.3个侵蚀 vs 0.4个,p<0.0001)。结论认为在本队列中,早期未分化关节炎治疗下的临床与影像学病程不依赖于诊断时≥3个关节侵蚀。
要点
- 早期未分化关节炎中,不符合2010年ACR/EULAR标准者按诊断时有无≥3个关节侵蚀分为影像学与非影像学关节炎两组。
- 随访期间两组DAS-28和HAQ评分无差异,但初始无影像学关节炎组侵蚀评分进展更高(每年3.3 vs 0.4,p<0.0001)。
- 在本队列中,早期未分化关节炎治疗下的临床与影像学病程不依赖于诊断时≥3个关节侵蚀。
核心结论
- 在本队列中,早期未分化关节炎在治疗下的临床与影像学病程不依赖于诊断时是否存在≥3个关节侵蚀(即EULAR工作组对影像学关节炎的定义)。
研究设计与样本
- 瑞士类风湿关节炎队列SCQM内的前瞻性观察研究,纳入病程≤1年、既往未接受任何DMARDs的早期未分化关节炎患者。
- 将不符合2010年ACR/EULAR分类标准的患者按有无EULAR工作组定义的影像学侵蚀性疾病(≥3个关节侵蚀)分为影像学关节炎组与非影像学关节炎组。
- 主要结局为采用Ratingen侵蚀评分检测的影像学进展,次要结局为HAQ和DAS-28,平均观察期4年。
主要发现
- 共分析592例患者,其中240例在基线不符合2010年ACR/EULAR分类标准;57例首次就诊时X线片不可用,133例为影像学关节炎、50例为非影像学关节炎。
- 所有患者均启动DMARDs治疗,大多为甲氨蝶呤。
- 随访期间两组DAS-28和HAQ评分无差异。
- 初始影像学关节炎组在整个研究期间平均侵蚀评分更高。
- 初始非影像学关节炎组侵蚀评分随时间进展更高(每年3.3个侵蚀 vs 每年0.4个,p<0.0001)。
关键数值与推荐
- 影像学关节炎定义为EULAR工作组定义的侵蚀性疾病,即≥3个关节有侵蚀。
- 主要结局采用Ratingen侵蚀评分评估影像学进展。
- 初始非影像学关节炎组侵蚀评分进展为每年3.3个侵蚀,初始影像学关节炎组为每年0.4个,p<0.0001。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyse whether early arthritis patients who do not fulfil the American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) 2010 classification criteria for rheumatoid arthritis (RA) have a different course of the disease dependent on whether they can or cannot be classified as RA because of radiographic disease (EULAR task force) at diagnosis. METHODS: For this observational study within the Swiss RA cohort SCQM, we included patients with early undifferentiated arthritis (disease duration ≤1 year), who had not received any previous disease-modifying antirheumatic drugs (DMARDs). 2010 ACR/EULAR criteria negative patients were separated into two groups (radiographic vs non-radiographic arthritis) depending on whether or not they had radiographic changes defined as erosive disease by a EULAR task force (≥3 joints with erosions). The primary outcome measure was the radiographic progression detected employing the Ratingen erosion score. Health Assessment Questionnaire (HAQ) and DAS-28 were used as secondary outcome measures. The average observation period was 4 years. RESULTS: A total of 592 patients were analysed. 240 were not classifiable as RA by application of the 2010 ACR/EULAR criteria at baseline. In 57 patients, radiographs at the first visit were not available. 133 patients had radiographic arthritis and 50 non-radiographic arthritis. Treatment was initiated in all patients with DMARDs, mostly methotrexate. No differences in DAS-28 and HAQ scores were found during follow-up. The average erosion scores were higher among patients with initially radiographic arthritis throughout the study. The progression of erosion scores over time, however, was higher in patients with initially non-radiographic arthritis with less subsequent radiological progression (3.3 erosions/year vs 0.4, respectively, p<0.0001). CONCLUSIONS: The clinical and radiographic course of early undifferentiated arthritis under treatment was not dependent on the presence of erosions in three or more joints (ie, the definition of radiographic disease by the EULAR task force) at diagnosis in our cohort.
引用
- Mueller RB, Kaegi T, Haile SR, et al. Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort. RMD Open. 2018. PMID: 29955385. doi:10.1136/rmdopen-2018-000673
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。